LHC Group (NASDAQ:LHCG) issued its quarterly earnings data on Monday. The health services provider reported $0.64 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.60 by $0.04, Bloomberg Earnings reports. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company had revenue of $272.90 million during the quarter, compared to analysts’ expectations of $265.35 million. During the same quarter in the previous year, the business earned $0.54 earnings per share. The firm’s revenue for the quarter was up 18.2% on a year-over-year basis.
LHC Group (NASDAQ:LHCG) traded up $1.90 during trading on Monday, hitting $73.72. The stock had a trading volume of 25,802 shares, compared to its average volume of 143,431. LHC Group has a twelve month low of $36.29 and a twelve month high of $76.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.75 and a quick ratio of 1.75. The stock has a market capitalization of $1,312.87, a PE ratio of 32.21, a PEG ratio of 2.18 and a beta of 0.70.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of the company’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $65.34, for a total transaction of $173,151.00. Following the completion of the sale, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 14.80% of the stock is owned by corporate insiders.
A number of brokerages have weighed in on LHCG. SunTrust Banks, Inc. reiterated a “buy” rating and issued a $75.00 price objective on shares of LHC Group in a research note on Friday. Zacks Investment Research cut LHC Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Robert W. Baird reiterated a “hold” rating and issued a $63.00 price objective on shares of LHC Group in a research note on Tuesday, September 12th. Royal Bank Of Canada reiterated a “buy” rating and issued a $70.00 price objective on shares of LHC Group in a research note on Wednesday, September 6th. Finally, Bank of America Corporation began coverage on LHC Group in a research note on Monday, August 21st. They issued a “buy” rating and a $76.00 price objective for the company. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. LHC Group currently has an average rating of “Buy” and a consensus price target of $68.50.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
What are top analysts saying about LHC Group? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for LHC Group and related companies.